Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1203140
Max Phase: Preclinical
Molecular Formula: C20H26ClN3O4
Molecular Weight: 371.44
Molecule Type: Small molecule
Associated Items:
ID: ALA1203140
Max Phase: Preclinical
Molecular Formula: C20H26ClN3O4
Molecular Weight: 371.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccccc1N1CCN(CC(O)c2ccc(O)c(C(N)=O)c2)CC1.Cl
Standard InChI: InChI=1S/C20H25N3O4.ClH/c1-27-19-5-3-2-4-16(19)23-10-8-22(9-11-23)13-18(25)14-6-7-17(24)15(12-14)20(21)26;/h2-7,12,18,24-25H,8-11,13H2,1H3,(H2,21,26);1H
Standard InChI Key: BWIWGOAPWLFLKA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 371.44 | Molecular Weight (Monoisotopic): 371.1845 | AlogP: 1.36 | #Rotatable Bonds: 6 |
Polar Surface Area: 99.26 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.21 | CX Basic pKa: 7.21 | CX LogP: 1.76 | CX LogD: 1.76 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.71 | Np Likeness Score: -0.96 |
1. Grisar JM, Claxton GP, Bare TM, Dage RC, Cheng HC, Woodward JK.. (1981) Salicylamide derivatives related to medroxalol with alpha- and beta-adrenergic antagonist and antihypertension activity., 24 (3): [PMID:6115059] [10.1021/jm00135a017] |
Source(1):